Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec
Fierce Pharma
Mon, 12/19/22 - 12:29 pm
AstraZeneca
Imfinzi
lung cancer
non-small cell lung cancer
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
AstraZeneca
Daiichi Sankyo
Pfizer
Roche
CSL
uniQure
Novo Nordisk
Eli Lilly
AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort
Fierce Pharma
Fri, 12/16/22 - 11:08 am
AstraZeneca
Symbicort
patents
Viatris
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
Fri, 12/16/22 - 10:47 am
AstraZeneca
Alexion
PNH
Ultomiris
Soliris
Roche
Apellis
Novartis
AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer
Fierce Pharma
Thu, 12/15/22 - 11:01 am
AstraZeneca
Merck
Lynparza
FDA
metastatic castration-resistant prostate cancer
ASH: Novartis says rare disease med 'stands on its own,' diving deeper into head-to-head win against AstraZeneca
Fierce Biotech
Tue, 12/13/22 - 10:28 am
ASH 2022
Novartis
iptacopan
AstraZeneca
ASH: Roche records phase 3 rare disease win ahead of Soliris showdown
Fierce Biotech
Mon, 12/12/22 - 10:29 am
ASH 2022
Roche
PNH
crovalimab
AstraZeneca
Soliris
AstraZeneca-Daiichi Sankyo’s therapy shows response in breast cancer trials
Clinical Trials Arena
Mon, 12/12/22 - 10:26 am
AstraZeneca
Daiichi Sankyo
clinical trials
datopotamab deruxtecan
metastatic triple-negative breast cancer
breast cancer
SABCS: AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla
Fierce Pharma
Fri, 12/9/22 - 10:54 am
SABCS
AstraZeneca
Enhertu
breast cancer
Daiichi Sankyo
Roche
Kadcyla
Setting the Stage for ASH 2022
BioSpace
Fri, 12/9/22 - 10:50 am
ASH 2022
AstraZeneca
Janssen
Merck
Vega Therapeutics
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Fierce Biotech
Fri, 12/9/22 - 10:46 am
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
Gilead Sciences
With Neogene buy and a CAR-T in the clinic, AstraZeneca builds up cell therapy 'library'
Fierce Biotech
Mon, 12/5/22 - 11:04 am
AstraZeneca
Neogene Therapeutics
CAR-T
cell therapy
cell library
AstraZeneca Deepens Cancer Cell Therapy Portfolio with Neogene Buyout
BioSpace
Tue, 11/29/22 - 11:12 am
AstraZeneca
Neogene Therapeutics
M&A
cancer
cell therapy
Lundbeck-partnered preclinical biotech nabs Series A from AstraZeneca
Endpoints
Tue, 11/29/22 - 11:00 am
Rgenta Therapeutics
AstraZeneca
funding
small molecule drugs
The problem with Her2-low testing
EP Vantage
Mon, 11/28/22 - 07:34 pm
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
diagnostics
HER2-low breast cancer
AstraZeneca, C4XD sign exclusive $402 million global license
Pharmaphorum
Mon, 11/28/22 - 10:20 am
AstraZeneca
C4XD
drug development
COPD
Pulling back the curtain on AstraZeneca’s CAR-T work
EP Vantage
Fri, 11/18/22 - 10:23 am
AstraZeneca
CAR-T
AZD0754
cell theray
GSK, J&J and AZ top global drug access index, but foundation says plenty more work needs to be done
Fierce Pharma
Thu, 11/17/22 - 12:13 pm
GSK
JNJ
AstraZeneca
Access to Medicine Foundation
drug access
AstraZeneca Launches Phase II Trial of Anti-TIGIT NSCLC Therapy
BioSpace
Wed, 11/16/22 - 11:24 pm
AstraZeneca
clinical trials
non-small lung cancer
AZD2936
AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions
Fierce Pharma
Mon, 11/14/22 - 07:10 pm
Europe
AstraZeneca
Sanofi
COVID-19
cancer
GSK
Regeneron
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »